Quality of care and risk of incident atrial fibrillation in patients with newly diagnosed heart failure: a nationwide cohort study.


Journal

European heart journal. Quality of care & clinical outcomes
ISSN: 2058-1742
Titre abrégé: Eur Heart J Qual Care Clin Outcomes
Pays: England
ID NLM: 101677796

Informations de publication

Date de publication:
17 08 2022
Historique:
received: 08 03 2021
revised: 28 04 2021
accepted: 05 05 2021
pubmed: 9 5 2021
medline: 19 8 2022
entrez: 8 5 2021
Statut: ppublish

Résumé

Incident atrial fibrillation (AF) is an adverse prognostic indicator in heart failure (HF); identifying modifiable targets may be relevant to reduce the incidence and morbidity of AF. Therefore, we examined the association between quality of HF care and risk of AF. Using the Danish Heart Failure Registry, we conducted a nationwide registry-based cohort study of all incident HF patients diagnosed between 2008 and 2018 and without history of AF. Quality of HF care was assessed by seven process performance measures, including echocardiographic examination, New York Heart Association classification, treatment with angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, beta-blockers, and mineralocorticoid antagonists, physical training, and patient education. In the main analysis, we examined adherence with all measures in a cohort of 25 100 patients (mean age 68.5 ± 13.2 years; 33.6% women). The median follow-up was 3.1 years. Cox proportional hazard regressions estimated the hazard ratios (HRs) with 95% confidence intervals (95% CIs) between the number of fulfilled measures and incident AF. In a multivariable-adjusted analysis with 0 fulfilled performance measures as reference, the HRs (95% CIs) were 1: 0.78 (0.61-1.00), 2: 0.63 (0.49-0.80), 3: 0.53 (0.36-0.80), 4: 0.64 (0.44-0.94), 5: 0.56 (0.39-0.82), 6: 0.51 (0.35-0.74), and 7: 0.49 (0.33-0.73), with a significant decreasing linear trend (P < 0.001). In patients with incident HF, fulfilment of guideline-based process performance measures was associated with decreased long-term risk of AF. This study supports initiatives to improve the quality of care for patients with HF to prevent incident AF.

Identifiants

pubmed: 33963404
pii: 6272224
doi: 10.1093/ehjqcco/qcab036
pmc: PMC9989597
doi:

Substances chimiques

Adrenergic beta-Antagonists 0
Angiotensin Receptor Antagonists 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

539-547

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL092577
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141434
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL120163
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG066010
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG066914
Pays : United States

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Références

Basic Clin Pharmacol Toxicol. 2020 Jul;127(1):30-38
pubmed: 32003944
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Circulation. 2002 Dec 10;106(24):3068-72
pubmed: 12473553
Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e000099
pubmed: 33136435
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
Scand Cardiovasc J. 2016 Oct - Dec;50(5-6):323-328
pubmed: 27454413
Circulation. 2016 Feb 2;133(5):484-92
pubmed: 26746177
Circulation. 2020 Jun 9;141(23):1915-1926
pubmed: 32511001
Int J Epidemiol. 2017 Jun 1;46(3):798-798f
pubmed: 27789670
Eur Heart J. 2004 Sep;25(18):1614-9
pubmed: 15351160
Circ Heart Fail. 2011 Nov;4(6):740-6
pubmed: 21920917
Circulation. 2012 May 15;125(19):2382-401
pubmed: 22528524
Stat Med. 2009 Jul 10;28(15):1982-98
pubmed: 19452569
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Circ Heart Fail. 2013 May;6(3):606-19
pubmed: 23616602
Circ Cardiovasc Qual Outcomes. 2010 May;3(3):309-15
pubmed: 20388872
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
Circulation. 2017 Aug 8;136(6):e137-e161
pubmed: 28455343
Int J Qual Health Care. 2003 Dec;15 Suppl 1:i5-11
pubmed: 14660518
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):37-43
pubmed: 22235067
Scand Cardiovasc J. 2017 Aug;51(4):183-189
pubmed: 28366010
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366
pubmed: 30025570
Health Serv Res. 2008 Oct;43(5 Pt 1):1464-84
pubmed: 22568614
Clin Epidemiol. 2016 Oct 25;8:497-502
pubmed: 27822090
Dan Med Bull. 2006 Nov;53(4):441-9
pubmed: 17150149
BMJ Open. 2016 Nov 18;6(11):e012832
pubmed: 27864249

Auteurs

Nicklas Vinter (N)

Diagnostic Centre, University Clinic for Development of Innovative Patient Pathways, Silkeborg Regional Hospital, Falkevej 3, 8600 Silkeborg, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Danish Center for Clinical Health Services Research, Aalborg University, Aalborg, Denmark.

Pia Cordsen (P)

Danish Center for Clinical Health Services Research, Aalborg University, Aalborg, Denmark.

Morten Fenger-Grøn (M)

Research Unit for General Practice, Aarhus, Denmark.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest & Heart Hospital, Liverpool, UK.
Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Emelia J Benjamin (EJ)

Department of Medicine, Boston University School of Medicine, USA.

Lars Frost (L)

Diagnostic Centre, University Clinic for Development of Innovative Patient Pathways, Silkeborg Regional Hospital, Falkevej 3, 8600 Silkeborg, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Søren Paaske Johnsen (SP)

Department of Epidemiology, Boston University School of Public Health, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH